AA Rewind 2017: Spine and Pain
Member Price: $79.00
Nonmember Price: $169.00
Resident Price:$39.00
Nonmember Resident Price: $89.00
Release Date: December 2017
Release Date: December 2017
CME Expiration Date: December 31, 2020
NOTE: The Academy will not issue any refunds or exchanges for products purchased online. Purchased online activities are removed from "My Education (Mē)" after their expiration date. Please review the entire product description prior to purchase.
Description
This product contains recorded sessions that took place during the Academy's Annual Assembly held in Denver, CO from October 12-15, 2017.
The following sessions are included in this product:
Effects of CDC Guidelines for Opioid Management on Physiatric Practices in Different Regions of the Country: What’s Next in Your Region?
Don’t Get Fooled: How to Identify Statistical Weakness in Clinical Pain Studies Part I: A Lecture Session in Collaboration With the Spine Intervention Society (SIS)
Therapeutic Cannabis Programs State-of-the-Art Review 2017: State/Federal Regulatory Issues, Patient Benefits/Controversies, and Medical-Legal Aspects for Clinicians/Patients
Spine Papers 2017
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of CreditT
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
The following sessions are included in this product:
Effects of CDC Guidelines for Opioid Management on Physiatric Practices in Different Regions of the Country: What’s Next in Your Region?
James W. Atchison, DO, FAAPMR (Session Director); JosephAudette, MD; Alan S. Hamilton, MD; Frank Lagattuta, MD, FAAPMR;Shana Margolis, MD, FAAPMR; Rick A. Pellant, DO, FAAPMR; MaxShokat, DO, FAAPMR; Steven P. Stanos, Jr., DO, FAAPMR
Don’t Get Fooled: How to Identify Statistical Weakness in Clinical Pain Studies Part I: A Lecture Session in Collaboration With the Spine Intervention Society (SIS)
D.J. Kennedy, MD, FAAPMR; Ameet S. Nagpal, MD, MS, MEd,FAAPMR (Session Directors); Brian T. Boies, MD; Byron J.Schneider, MD, FAAPMR
Therapeutic Cannabis Programs State-of-the-Art Review 2017: State/Federal Regulatory Issues, Patient Benefits/Controversies, and Medical-Legal Aspects for Clinicians/Patients
Stuart J. Glassman, MD, FAAPMR (Session Director);Gregory T. Carter, MD, MS, FAAPMR; Mitchell Prywes, MD, FAAPMR
Spine Papers 2017
David S. Cheng, MD, FAAPMR (Session Director)
Method of Study
Each session contains video presentations that were recorded during the Annual Assembly. Upon viewing the presentations, participants will need to complete a session evaluation, which includes a reflection on learning, in order to claim credit. The presentations can be viewed at one's own pace and credit can be claimed after viewing the individual sessions.
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of CreditT
he American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
AAPM&R Medical Education Committee:
Steven R. Flanagan, MD, Chair: Disclosed no relevant financial relationships.
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
John C. Cianca, MD: Speaker’s Bureau for Advanced Health Education Center
Claire E. Finkel, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Cerner Corporation: Non-remunerative Positions of Influence; NU School of Physical Therapy: Honorarium
R. Sam Mayer, MD: Demos Publishing: Receipt of Royalties.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speaker's Bureau for Allergan; has non-remunerative positions of influence with the AAOS Guideline Committee; and has participated on clinical trials for Ipsen, Merz, and Revance.
Amy Phelan, MD, DVM: Disclosed no relevant financial relationships.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Demos Publishing: Receipt of Royalties; American Board of Physical Medicine and Rehabilitation: Board of Directors
Nathaniel V. Zuziak, DO: Disclosed no relevant financial relationships.
AAPM&R CME Committee:
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
John C. Cianca, MD: Speaker’s Bureau for Advanced Health Education Center
Claire E. Finkel, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Cerner Corporation: Non-remunerative Positions of Influence; NU School of Physical Therapy: Honorarium
R. Sam Mayer, MD: Demos Publishing: Receipt of Royalties.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speaker's Bureau for Allergan; has non-remunerative positions of influence with the AAOS Guideline Committee; and has participated on clinical trials for Ipsen, Merz, and Revance.
Amy Phelan, MD, DVM: Disclosed no relevant financial relationships.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Demos Publishing: Receipt of Royalties; American Board of Physical Medicine and Rehabilitation: Board of Directors
Nathaniel V. Zuziak, DO: Disclosed no relevant financial relationships.
AAPM&R CME Committee:
Kerrie M. Reed, MD, Chair: Disclosed no relevant financial relationships.
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA DisclosuresAll faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA DisclosuresAll faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.